This is an aggregated industry headline. Read the full story at FiercePharma →
US to investigate Germany's proposed drug spending reforms
Amid efforts in Germany to retool the country's drug spending, the U.S. is launching an investigation into what the Office of the United States Trade Representative has branded "persistent underpayment" by the European nation for new meds.
By FiercePharma
· Jun 23, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
Exelixis' next franchise drug, zanzalintinib, has hit a clinical setback, although at least two groups of anal…
The WeekBriefing
China grants CARsgen approval for a Claudin18.2-targeted therapy, marking the first CAR-T authorized for solid…
The WeekSTAT News ↗
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to a…